Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS). 

Biotechnology

Passage Bio

William Chou

Patricia Elsasser

Emily Winters

Chelsea Difebbo Ortiz

Anne Marie Pierce

Steve Krausert

Glen Kerker II

Nripen Singh

Sue Browne

Stuart Henderson

Tiffini Voss

Eden Fucci

Kathleen Borthwick

Alex Fotopoulos

Edgar B. Cale

Samiah Al-Zaidy

Mark Forman

Jiwen Zhang

James M. Wilson

The executive team at Passage Bio has a history of working in the pharmaceutical industry and in academia. The team members have worked at companies such as ACADIA Pharmaceuticals Inc. and Merck, and have also been an Assistant Professor at the University of Pennsylvania. The team's education histories include degrees from Duke University School of Medicine and The Rockefeller University.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Passage Bio

Leadership Team

Board of Directors